Xospata
Generic: gilteritinib
- Manufacturer
- Astellas
- NDC
- 0469-1425
- RxCUI
- 2105811
- Route
- ORAL
- ICD-10 indication
- C92.02
Affordability Check
How much will you actually pay for Xospata?
In 30 seconds, see every legitimate way to afford Xospata — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Xospata
What is this medication? Xospata, which contains the active ingredient gilteritinib, is a prescription medicine used to treat adults with a specific type of blood cancer called acute myeloid leukemia. This medication is specifically indicated for patients whose cancer has come back or has not improved after previous treatments. It is designed for use in individuals whose leukemia cells have a mutation in a gene called FLT3, which is identified through a specialized diagnostic test.
As a kinase inhibitor, Xospata works by blocking the activity of certain proteins that signal cancer cells to grow and divide. By targeting the FLT3 protein, the drug helps to slow down or stop the progression of the leukemia. This targeted therapy approach is different from traditional chemotherapy, as it focuses on the specific genetic markers present in the patient's cancer cells to help manage the disease more effectively.
Copay & patient assistance
- Patient Copay Amount: As little as $0 per prescription
- Maximum Annual Benefit Limit: $7,000 per calendar year
- Core Eligibility Restrictions: Must have commercial prescription insurance; not valid for patients whose claims are reimbursed by any state or federal government program (including but not limited to Medicaid, Medicare, Medigap, DoD, VA, or TRICARE); not valid for cash-paying patients; must reside in the 50 United States, Washington DC, Puerto Rico, Guam, or the Virgin Islands; no income requirements.
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for gilteritinib.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Xospata →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for gilteritinib →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How Xospata appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
72%
3,966 of 5,499 plans
Most common tier
Tier 5
On 79% of covering formularies
Prior authorization required
99%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 59 | 18% |
| Tier 2 (generic) | 2 | 1% |
| Tier 4 (non-preferred brand) | 7 | 2% |
| Tier 5 (specialty) | 259 | 79% |
| Tier 6 | 1 | 0% |
Step therapy: 0% of formularies
Quantity limits: 84% of formularies
Coverage breadth: 328 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Mercaptopurine
Treats same condition · Mercaptopurine
Elliotts B
Treats same condition · sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate
Mitoxantrone
Treats same condition · Mitoxantrone
Isoniazid
Treats same condition · Isoniazid
Bendamustine
Treats same condition · BENDAMUSTINE HYDROCHLORIDE
TIBSOVO
Treats same condition · ivosidenib
Tasigna
Treats same condition · nilotinib
Allopurinol
Treats same condition · Allopurinol
GRAFAPEX
Treats same condition · treosulfan
IMKELDI
Treats same condition · imatinib oral
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
Xospata treats a rare condition. For in-depth disease pages on our sister site:
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.